亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Achiral Peptoids and Variations for Treating Alzheimer's Disease

詳細技術說明: Alzheimer’s disease is a devastating disease that progressively robs the memory and the mental abilities of the patient. There currently is no cure for Alzheimer’s, or even a treatment to slow the progression of the disease. Alzheimer’s disease affects more than 26.6 million people worldwide and is predicted to affect 1 in 85 people globally by 2050. Although there is no conclusive known cause of the disease, the presence of beta-amyloid plaques in the brain is associated with the disease and its symptoms. New peptoids have been created that prevent the aggregation of the beta amyloids, and may break up existing amyloids. These peptoids are currently being tested and research is on-going. The new peptoids may be developed into drugs which could be administered to Alzheimer’s patients to prevent further damage to their brains, and possibly even to reverse the effects of the disease.For additional information on the research, see this article http://vpred.uark.edu/documents/techventures/tech_docs/acs_article_4-1-14.pdf

*Principal Investigation: Name: Shannon Servoss, Assistant Professor
Department:

Name: James Turner, Research Assistant
Department: Chemical Engineering

欲了解更多信息，請點擊這裡